Respiratory Viruses: New Frontiers - RESCHEDULING IN PROGRESS
joint with Viral Immunity: Basic Mechanisms and Therapeutic Applications - RESCHEDULING IN PROGRESS
Scientific Organizers: Kanta Subbarao, JoAnn A. Suzich and Carolina B. López
Date: February 05 - 09, 2021
Location: Fairmont Banff Springs, Banff, AB, Canada
For important information on the coronavirus, please click here
Respiratory viruses continue to pose medical challenges. The lung is susceptible to infection by multiple viruses each with unique mechanisms of interacting with the human host and evading the immune system. Respiratory infections are relatively easy to contract and are associated with significant morbidity and mortality. Despite many years of study, our ability to prevent and treat these infectious is limited. This Keystone Symposia conference will focus on novel insights into respiratory virus biology that may ultimately lead to more effective prevention and treatment strategies. In many cases, these novel insights are made possible by new tools that are now available to study pathogens whose infectious cycle is largely restricted to the airways – making visible what was previously invisible. New information about virus host interactions will be discussed, as well as the interplay among diverse organisms present in the host airways. The long-term ramifications of respiratory virus infections beyond acute disease will be explored along with both recent successes and failures in prevention and treatment. This conference is a joint symposium with Viral Immunity: Basic Mechanisms and Therapeutic Applications and will have a few combined sessions. Finally, our conference will bring together scientists studying different respiratory viruses using diverse approaches from the perspective of the pathogens and host, recognizing that it is at the intersection of disciplines where opportunities for innovation and novel insight lie.
We gratefully acknowledge the generous grant for this conference provided by:National Institute of Allergy and Infectious Diseases (NIAID)
Grant No. 1R13AI154969-01
Funding for this conference was made possible (in part) by 1R13AI154969-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.